Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up

This study presents the longest prospective, multicenter follow-up of pallidal neurostimulation in generalized and segmental dystonia. Two-thirds of patients showed strong and stable long-term improvements of dystonia, confirming sustained efficacy and safety over 10 years in treatment-refractory dystonic patients. However, one-third experienced primary (3/40) or secondary (10/40) treatment failure. Diagnostic advances, including genetic testing, and technological progress in pallidal neurostimulation may help to reduce the non-responder rates in the future. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-02-05
DOI
https://doi.org/10.1002/mds.30130
Citations
5
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
6.95

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up

Jan‐Uwe Müller, Andrea A. Kühn, Alfons Schnitzler, Jan Vesper et al.
5 citations
Movement Disorders
Neurological disorders and treatments
6.95
article

Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up

Jan‐Uwe Müller, Andrea A. Kühn, Alfons Schnitzler, Jan Vesper, R. Erasmi, Inger Marie Skogseid, Jens Volkmann, Wilhelm Eisner, Nils Warneke, Patricia Krause, Tobias Warnecke, Gerd‐Helge Schneider, Thomas Prokop, Frank Steigerwald, Günther Deuschl, Philipp Mahlknecht, Jörg Müller, Werner Poewe
article en
5 citations

Abstract

This study presents the longest prospective, multicenter follow-up of pallidal neurostimulation in generalized and segmental dystonia. Two-thirds of patients showed strong and stable long-term improvements of dystonia, confirming sustained efficacy and safety over 10 years in treatment-refractory dystonic patients. However, one-third experienced primary (3/40) or secondary (10/40) treatment failure. Diagnostic advances, including genetic testing, and technological progress in pallidal neurostimulation may help to reduce the non-responder rates in the future. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(6)
Oslo University Hospital (NO), Innsbruck Medical University (AT), University of Freiburg (DE), University of Münster (DE), University of Würzburg (DE), Universitätsmedizin Greifswald (DE), Christian-Albrechts-Universität zu Kiel (DE), Vivantes Klinikum (DE), Klinikum Osnabrück (DE), Heinrich Heine University Düsseldorf (DE), Charité - Universitätsmedizin Berlin (DE)
Deutsche Forschungsgemeinschaft
Openalex Percentile: Top 3%
Neurological disorders and treatments
6.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.